Dr. Clarissa Whitehead, PhDSenior Research Officer at Burnet InstituteSpeaker
Profile
Clarissa is a Senior Research Officer in the Immune Therapies Group at the Burnet Institute and a co-inventor of Stellabody® technology - an innovative antibody engineering platform that enhances therapeutic potency by promoting on-target antibody hexamer formation.
Her research background spans both academic and commercial settings, from investigating disease progression in malignant glioma to leading antibody and exosome engineering projects supporting the development and commercialisation of novel therapeutics. With a strong focus on translational science that can shape the future of healthcare, Clarissa is passionate about advancing next-generation biologics to address unmet clinical needs and improve patient outcomes.
Agenda Sessions
Stellabody® Transforms Killing and Agonism Potency of Antibody and Ig-like Biologics
, 10:00View Session